Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies

[1]  S. Ng,et al.  The epidemiology of inflammatory bowel disease: East meets west , 2019, Journal of gastroenterology and hepatology.

[2]  Y. Oo,et al.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease , 2019, Clinical and experimental immunology.

[3]  E. Lightcap,et al.  Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD , 2019, BMC Immunology.

[4]  M. Neurath,et al.  Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing , 2019, Gut.

[5]  J. Clemente,et al.  Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. , 2019, Gastroenterology.

[6]  J. Andrews,et al.  Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial , 2019, JAMA.

[7]  S. Hanauer,et al.  Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  F. Blachier,et al.  Colon epithelial cells luminal environment and physiopathological consequences: impact of nutrition and exercise , 2018, Nutrire.

[9]  J. Panés,et al.  Tofacitinib for the treatment of ulcerative colitis , 2018, Expert review of clinical immunology.

[10]  J. Allaire,et al.  The Intestinal Epithelium: Central Coordinator of Mucosal Immunity. , 2018, Trends in immunology.

[11]  M. Scribano.  Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence , 2018, World journal of gastroenterology.

[12]  T. Spector,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[13]  Shanshan Kong,et al.  Regulation of Intestinal Epithelial Cells Properties and Functions by Amino Acids , 2018, BioMed research international.

[14]  J. Xu,et al.  What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab? , 2018, Inflammatory bowel diseases.

[15]  Zhaohua Shen,et al.  Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation , 2018, World journal of gastroenterology.

[16]  M. Mohajeri,et al.  Probiotics and the Gut Immune System: Indirect Regulation , 2017, Probiotics and Antimicrobial Proteins.

[17]  N. Ajami,et al.  Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis , 2017, Inflammatory bowel diseases.

[18]  S. Chikuma.  CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation. , 2017, Current topics in microbiology and immunology.

[19]  Lu Wei,et al.  Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis , 2016, PloS one.

[20]  F. Ghishan,et al.  Physiology of Intestinal Absorption and Secretion. , 2016, Best practice & research. Clinical gastroenterology.

[21]  R. Russell,et al.  Management of ulcerative colitis , 2015, Archives of Disease in Childhood.

[22]  J. Barrett,et al.  Understanding inflammatory bowel disease via immunogenetics. , 2015, Journal of autoimmunity.

[23]  Hanan Khalil,et al.  Crohn’s disease: a clinical update , 2015, Therapeutic advances in gastroenterology.

[24]  Y. Nasser,et al.  Vasoactive Intestinal Polypeptide Promotes Intestinal Barrier Homeostasis and Protection Against Colitis in Mice , 2015, PloS one.

[25]  H. Ahn,et al.  Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012: A Nationwide Population-based Study , 2015, Inflammatory bowel diseases.

[26]  R. Newberry,et al.  Microbial Sensing by Goblet Cells Controls Immune Surveillance of Luminal Antigens in the Colon , 2014, Mucosal Immunology.

[27]  T. Raine.  Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same? , 2014, United European gastroenterology journal.

[28]  P. Sarlós,et al.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. , 2014, World journal of gastrointestinal pathophysiology.

[29]  A. Levy,et al.  Decreasing incidence of inflammatory bowel disease in Eastern Canada: a population database study , 2014, BMC Gastroenterology.

[30]  A. Lyra,et al.  Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. , 2014, World journal of gastroenterology.

[31]  M. Coskun.  Intestinal Epithelium in Inflammatory Bowel Disease , 2014, Front. Med..

[32]  H. Al‐Salami,et al.  Inflammatory bowel disease: clinical aspects and treatments , 2014, Journal of inflammation research.

[33]  S. Xiao,et al.  Histological evaluation in ulcerative colitis , 2014, Gastroenterology report.

[34]  G. Friedlander,et al.  Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. , 2014, Immunity.

[35]  A. Stensballe,et al.  Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. , 2014, World journal of gastroenterology.

[36]  B. Grimbacher,et al.  IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. , 2014, Current topics in microbiology and immunology.

[37]  S. Danese,et al.  New therapeutic avenues in ulcerative colitis: thinking out of the box , 2013, Gut.

[38]  R. Feakins,et al.  Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines , 2013, Journal of Clinical Pathology.

[39]  L. Ferguson,et al.  Why interleukin-10 supplementation does not work in Crohn's disease patients. , 2013, World journal of gastroenterology.

[40]  P. Lakatos,et al.  The burden of inflammatory bowel disease in Europe. , 2013, Journal of Crohn's & colitis.

[41]  A. M’Koma,et al.  Inflammatory Bowel Disease: An Expanding Global Health Problem , 2013, Clinical medicine insights. Gastroenterology.

[42]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[43]  H. Flint,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[44]  M. Peppercorn,et al.  Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis , 2012, Drugs.

[45]  S. Iyer,et al.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. , 2012, Critical reviews in immunology.

[46]  K. Soga,et al.  Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and/or ribavirin , 2011, Journal of gastroenterology and hepatology.

[47]  N. Shroyer,et al.  Intestinal development and differentiation. , 2011, Experimental cell research.

[48]  D. Polk,et al.  Probiotics and immune health , 2011, Current opinion in gastroenterology.

[49]  S. Targan,et al.  Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts. , 2011, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[50]  B. Tijjani,et al.  Biomarkers in the management of ulcerative colitis: a brief review , 2011, German medical science : GMS e-journal.

[51]  Y. S. Kim,et al.  Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress , 2010, Current gastroenterology reports.

[52]  R. Panaccione,et al.  Review: Anti-adhesion molecule therapy for inflammatory bowel disease , 2010, Therapeutic advances in gastroenterology.

[53]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[54]  Leo K. Cheng,et al.  Gastrointestinal system , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.

[55]  U. Vogel,et al.  The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study , 2010, BMC Medical Genetics.

[56]  M. Peppercorn,et al.  Review: Ulcerative colitis: current treatment strategies and future prospects , 2009, Therapeutic advances in gastroenterology.

[57]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[58]  Alastair Forbes,et al.  Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease , 2008, Nature Genetics.

[59]  G. Kaplan,et al.  The Role of TNFα in Ulcerative Colitis , 2007 .

[60]  J. Rhodes,et al.  Ulcerative colitis: diagnosis and management , 2006, BMJ : British Medical Journal.

[61]  B. Xia,et al.  [Cytotoxic T lymphocyte antigen-4 promoter gene polymorphism is significantly associated with ulcerative colitis]. , 2006, Zhonghua nei ke za zhi.

[62]  N. Croft.  Phospholipid in UC: novel, safe and works--is it too good to be true? , 2006, Gastroenterology.

[63]  P. Gibson,et al.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? , 2005, Gut.

[64]  M. Neurath,et al.  Illuminating the role of type I IFNs in colitis. , 2005, The Journal of clinical investigation.

[65]  S. Czinn,et al.  Isolation and Purification of Colon Lamina Propria Dendritic Cells from Mice with Colitis , 2004, Cytotechnology.

[66]  A. D. Dzhalalov.  The physiology of the large intestine , 1957, Bulletin of Experimental Biology and Medicine.

[67]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[68]  Judy H. Cho,et al.  Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease , 2002, Clinical Microbiology Reviews.

[69]  J. Naismith,et al.  TNFα and the TNF receptor superfamily: Structure‐function relationship(s) , 2000, Microscopy research and technique.

[70]  S. Targan,et al.  Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope , 2000, Infection and Immunity.

[71]  N. Svartz.  The pathogenesis and treatment of ulcerative colitis. , 2009, Acta medica Scandinavica.